
    
      This study will evaluate the results of Corneal Collagen Crosslinking (CXL) in patients with
      conditions that include keratoconus, forme fruste keratoconus, post-LASIK ectasia, pellucid
      marginal degeneration, forme fruste pellucid marginal degeneration, diurnal fluctuation
      post-radial keratotomy, or Terrien's marginal degeneration. This is an outcomes study, all
      patients receive treatment.
    
  